<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study was designed to prospectively, endoscopically, and histologically determine the prevalence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in patients who had received adjuvant chemotherapy for localized <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Fifteen white women who received <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (N = 8) or <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, adriamycin, and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (N = 7) chemotherapy underwent esophagogastroduodenoscopy and esophageal biopsy a mean 31.1 months (median, 11 months) after completion of full-course chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Twelve of 15 patients had experienced <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulcerations</z:e>, <z:hpo ids='HP_0002014'>diarrhea</z:hpo>, or odynophagia during chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>In no patient was <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> identified endoscopically or histologically </plain></SENT>
<SENT sid="4" pm="."><plain>This study fails to demonstrate an increased prevalence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in <z:hpo ids='HP_0003002'>breast carcinoma</z:hpo> patients who had received adjuvant chemotherapy </plain></SENT>
</text></document>